# A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

> clinical trial · VERIFIED · 2026-08-18

Status: RECRUITING · Sponsor: Dianthus Therapeutics · Condition: Chronic Inflammatory Demyelinating Polyneuropathy

- Company: Dianthus Therapeutics
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06858579

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.